{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:10:32Z","timestamp":1761052232344,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"FCT to CICS","award":["PEst-OE\/SAU\/UI0709\/2014"],"award-info":[{"award-number":["PEst-OE\/SAU\/UI0709\/2014"]}]},{"name":"ARC-B"},{"DOI":"10.13039\/501100008530","name":"FEDER","doi-asserted-by":"crossref","award":["CENTRO-07-ST24-FEDER-002015"],"award-info":[{"award-number":["CENTRO-07-ST24-FEDER-002015"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.bcmd.2015.06.005","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T01:06:42Z","timestamp":1435021602000},"page":"208-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The JAK2V617F mutation is associated with anomalies in the frequency of monocytes, B cells, CD8+ T cells and NK cells"],"prefix":"10.1016","volume":"55","author":[{"given":"Ana R.","family":"Costa-Brito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa M.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7209-4507","authenticated-orcid":false,"given":"Fernando A.","family":"Arosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2015.06.005_bb0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1751-553X.2008.01102.x","article-title":"The classification and diagnosis of erythrocytosis","volume":"30","author":"McMullin","year":"2008","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.bcmd.2015.06.005_bb0010","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2011-02-292102","article-title":"New mutations and pathogenesis of myeloproliferative neoplasms","volume":"118","author":"Vainchenker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.06.005_bb0015","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1365-2141.2009.08069.x","article-title":"Advances in understanding the pathogenesis of primary familial and congenital polycythaemia","volume":"148","author":"Huang","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.06.005_bb0020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/asheducation.V2012.1.561.3807838","article-title":"The spectrum of JAK2-positive myeloproliferative neoplasms","volume":"2012","author":"Kiladjian","year":"2012","journal-title":"Hematol. Am. Soc. Hematol. Educ. Prog."},{"key":"10.1016\/j.bcmd.2015.06.005_bb0025","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/00029330-200809020-00005","article-title":"Involvement of CD4+CD25+ regulatory T cells in the pathogenesis of polycythaemia vera","volume":"121","author":"Zhao","year":"2008","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bcmd.2015.06.005_bb0030","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1182\/blood-2011-03-340992","article-title":"Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-\u03b1","volume":"118","author":"Riley","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.06.005_bb0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/ejh.12420","article-title":"Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-\u03b1","volume":"94","author":"Riley","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.06.005_bb0040","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.imbio.2010.09.012","article-title":"IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion","volume":"216","author":"Correia","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.bcmd.2015.06.005_bb0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/bjh.12099","article-title":"Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49,488 individuals from the general population","volume":"160","author":"Nielsen","year":"2013","journal-title":"Br. J. Haematol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615001059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615001059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:31:21Z","timestamp":1761049881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979615001059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1079979615001059"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.06.005","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The JAK2V617F mutation is associated with anomalies in the frequency of monocytes, B cells, CD8+ T cells and NK cells","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}